CY1113651T1 - Αντιφλεγμονωδη σκευασματα - Google Patents

Αντιφλεγμονωδη σκευασματα

Info

Publication number
CY1113651T1
CY1113651T1 CY20131100127T CY131100127T CY1113651T1 CY 1113651 T1 CY1113651 T1 CY 1113651T1 CY 20131100127 T CY20131100127 T CY 20131100127T CY 131100127 T CY131100127 T CY 131100127T CY 1113651 T1 CY1113651 T1 CY 1113651T1
Authority
CY
Cyprus
Prior art keywords
inflammatory preparations
inflammatory
preparations
compositions
peonyol
Prior art date
Application number
CY20131100127T
Other languages
English (en)
Inventor
Nicholas John Larkins
Original Assignee
Akl Inflammatory Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akl Inflammatory Limited filed Critical Akl Inflammatory Limited
Publication of CY1113651T1 publication Critical patent/CY1113651T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Emergency Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Συνθέσεις που περιέχουν αποκυνίνη και παιωνόλη. Οι συνθέσεις μπορούν να χρησιμοποιηθούν για τη θεραπεία φλεγμονωδών παθήσεων.
CY20131100127T 2005-04-08 2013-02-12 Αντιφλεγμονωδη σκευασματα CY1113651T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0507208A GB2424833B (en) 2005-04-08 2005-04-08 Anti-inflammatory formulation comprising apocyanin and paeonol
EP06726682A EP1868586B1 (en) 2005-04-08 2006-04-07 Anti-inflammatory formulation

Publications (1)

Publication Number Publication Date
CY1113651T1 true CY1113651T1 (el) 2016-06-22

Family

ID=34610865

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20131100127T CY1113651T1 (el) 2005-04-08 2013-02-12 Αντιφλεγμονωδη σκευασματα

Country Status (14)

Country Link
US (1) US8841348B2 (el)
EP (1) EP1868586B1 (el)
JP (2) JP2008534666A (el)
AU (1) AU2006232644B2 (el)
CA (1) CA2603512C (el)
CY (1) CY1113651T1 (el)
DK (1) DK1868586T3 (el)
ES (1) ES2398971T3 (el)
GB (1) GB2424833B (el)
NZ (1) NZ562770A (el)
PL (1) PL1868586T3 (el)
PT (1) PT1868586E (el)
SI (1) SI1868586T1 (el)
WO (1) WO2006106350A1 (el)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10933030B2 (en) 2005-05-06 2021-03-02 Angiolab, Inc. Use of paeonol for inhibiting angiogenesis or for enhancing radiosensitization
JP2007169247A (ja) * 2005-12-26 2007-07-05 Seikatsu Bunkasha:Kk ショウガ含有経口組成物
GB2436063A (en) * 2006-03-16 2007-09-19 Nicholas John Larkins Pharmaceutical composition for the treatment of excess mucous production
GB2463080A (en) * 2008-09-02 2010-03-03 Nicholas John Larkins Pharmaceutical preparation
WO2011044122A1 (en) * 2009-10-05 2011-04-14 Steven Charles Roberts Compositions and methods of treatment that include plant extracts
CN102079703B (zh) * 2010-12-16 2014-09-17 苏州大学 一种非甾体抗炎药制备方法及其抗炎镇痛作用
CN102440962B (zh) * 2011-12-28 2015-03-04 黑龙江大学 丹皮酚微小的储库型载体及提高丹皮酚抗氧化能力的方法
CN103127273B (zh) * 2013-03-12 2014-11-05 中国科学院新疆理化技术研究所 一种治疗慢性肝病的复方药物及其制备方法
CN104117029A (zh) * 2014-06-13 2014-10-29 安徽强英鸭业集团有限公司 一种用于缓解皮肤瘙痒的方法
CN104474285A (zh) * 2014-12-30 2015-04-01 张冬 一种治疗溃疡性结肠炎的中药汤剂及其制备方法
CN104689142A (zh) * 2015-04-09 2015-06-10 郑素娟 一种在医疗室中治疗类风湿性关节炎的药物的制备方法
ITUB20153879A1 (it) * 2015-09-24 2017-03-24 Professional Dietetics Spa Composizioni per il trattamento del dolore in pazienti sottoposti ad artroplastica elettiva
GB2547241A (en) * 2016-02-11 2017-08-16 Akl Res & Dev Ltd Anti-inflammatory formulation
CN107213295B (zh) * 2017-06-28 2018-06-22 云南金乌黑药制药有限公司 一种治疗风湿、中风类疾病的药物及其制备方法
GB2568698A (en) * 2017-11-23 2019-05-29 Akl Res & Development Ltd Formulation
CN109453157B (zh) * 2018-10-21 2020-10-09 魏群 一种重症急性胰腺炎肠黏膜屏障保护药物及其用途
CN111956634B (zh) * 2020-08-28 2023-01-13 陕西医药控股医药研究院有限公司 丹皮酚衍生物在保护血管内皮中的用途

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4647453A (en) * 1984-10-18 1987-03-03 Peritain, Ltd. Treatment for tissue degenerative inflammatory disease
DE4201942A1 (de) * 1991-02-26 1992-09-24 Plantamed Arzneimittel Gmbh Phenonverbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
WO1995022323A1 (en) * 1994-02-16 1995-08-24 Idun Pharmaceuticals Methods for controlling free radical generation by inflammatory cells
CN1130079A (zh) * 1995-03-01 1996-09-04 上海市伤骨科研究所 止痛消肿贴膏
GB9704904D0 (en) * 1997-03-10 1997-04-30 Riley Fletcher Foundation The Essential oil composition
JP3587665B2 (ja) * 1997-09-19 2004-11-10 甲陽ケミカル株式会社 グルコサミン塩含有ドリンク剤
US6194469B1 (en) * 1998-12-11 2001-02-27 Board Of Trustees Operating Michigan State Univeristy Method for inhibiting cyclooxygenase and inflammation using cherry bioflavonoids
JP2003526625A (ja) * 1999-07-23 2003-09-09 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 血小板の活性化の調節
US6733800B1 (en) * 1999-07-26 2004-05-11 Ashok Rajgarhia Synergistic composition for the treatment of liver and liver associated ailments and a process for preparing the same
ES2226477T3 (es) * 1999-07-26 2005-03-16 Ashok Rajgarhia Utilizacion de una composicion sinergica para la manufactura de un medicamento para tratamiento de dolencias relacionadas con el higado.
JP2001151679A (ja) * 1999-11-30 2001-06-05 Tama Seikagaku Kk リムルス反応を阻害するフラボノイド
US6492429B1 (en) * 2000-07-10 2002-12-10 N.V. Nutricia Composition for the treatment of osteoarthritis
GB2368012A (en) * 2000-10-19 2002-04-24 Nicholas John Larkins Preparation for the relief of inflammatory disease
CN1511549A (zh) * 2002-12-27 2004-07-14 张小丽 含有黄芩的抗肿瘤、抗炎症及肿瘤预防药物的组合物

Also Published As

Publication number Publication date
JP2013082745A (ja) 2013-05-09
US20090215886A1 (en) 2009-08-27
EP1868586A1 (en) 2007-12-26
AU2006232644A1 (en) 2006-10-12
CA2603512A1 (en) 2006-10-12
GB0507208D0 (en) 2005-05-18
EP1868586B1 (en) 2012-11-21
DK1868586T3 (da) 2013-03-11
SI1868586T1 (sl) 2013-04-30
JP2008534666A (ja) 2008-08-28
CA2603512C (en) 2016-06-07
PT1868586E (pt) 2013-02-27
WO2006106350A1 (en) 2006-10-12
JP5662492B2 (ja) 2015-01-28
GB2424833B (en) 2008-12-10
ES2398971T3 (es) 2013-03-25
US8841348B2 (en) 2014-09-23
PL1868586T3 (pl) 2013-05-31
NZ562770A (en) 2011-07-29
GB2424833A (en) 2006-10-11
AU2006232644B2 (en) 2011-11-10

Similar Documents

Publication Publication Date Title
CY1113651T1 (el) Αντιφλεγμονωδη σκευασματα
NO20082594L (no) Pyrimidinylbenzotiofenforbindelser
CY1115745T1 (el) Συνθεσεις και μεθοδοι για αντιμετωπιση ή προληψη σχετιζομενης με οξαλικα νοσου
CY1117937T1 (el) Φαρμακευτικες συνθεσεις ελεγχομενης αποδεσμευσης που περιλαμβανουν εστερα φουμαρικου οξεος
CY1119002T1 (el) Αναλογα πολυαιθερα δεσφεριθιοκινης
ECSP088503A (es) COMPUESTOS de LACTAMa y MÉTODOS DE USO DE LOS MISMOS
CY1105137T1 (el) Παραγωγα αμινοκυκλοεξυλ αιθερων και χρησεις τους
CY1112297T1 (el) Ετεροκυκλικοι αναστολεις της μεκ και μεθοδοι χρησης αυτων
CY1114397T1 (el) Φαρμακευτικες συνθεσεις οι οποιες περιλαμβανουν βακτηρια τα οποια μειωνουν οξαλικα
ATE461217T1 (de) Glp-1-verbindungen
ATE267830T1 (de) Als cox-hemmer verwendbare sulfonylphenylpyrazol- verbindungen
EA200900802A1 (ru) Способы и композиции для лечения амилоидных заболеваний
CY1110026T1 (el) Ενωσεις πιπεραζινης βενζισοξαζολης και μεθοδοι χρησης εξ αυτων
ECSP077401A (es) Medicamentos que contienen compuestos de carbonilo y su uso
ATE548374T1 (de) 2'-fluor-2'-desoxytetrahydrouridine als cytidindeaminaseinhibitoren
CY1113314T1 (el) (3-αρυλ-πιπεραζιν-1-υλ) παραγωγα της 6,7-διαλκοξυκιναζολινης, 6,7-διαλκοξυφθαλαζινης και 6,7-διαλκοξυϊσοκινολινης
ECSP024382A (es) Inhibidores de proteasa de serina
ATE471324T1 (de) Triazolophthalazine
ECSP055844A (es) Nuevos compuestos triciclicos
DE602006019832D1 (de) Isoflavonoiddimere
CY1105429T1 (el) Φαρμακευτικη συνθεση συνδυαζουσα τενατοπραζολη και ενα αντιφλεγμονωδες
CY1111983T1 (el) Φαρμακευτικη συνθεση και μεθοδος χρησης αντιμυκητιακου παραγοντα σε συνδυασμο
ECSP056006A (es) Composiciones farmacéuticas que comprenden una combinación de rapamicina o su derivado y pimecrolimus para el tratamiento de enfermedades inflamatorias e inmunológicamente mediadas
CY1117174T1 (el) ΧΡΗΣΗ 24-norUDCA ΓΙΑ ΤΗΝ ΑΓΩΓΗ ΧΟΛΟΣΤΑΤΙΚΩΝ ΝΟΣΗΜΑΤΩΝ ΤΟΥ ΗΠΑΤΟΣ
NO20060896L (no) Alfa-aminoamidderivater nyttige som antiinflammatoriske midler